Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of Neurotoxicity by FoxG1

• Published in: The Journal of neuroscience Vol. 32; no. 8; pp. 2846 - 2855
• Main Authors: Dastidar, Somasish Ghosh, Bardai, Farah H., Ma, Chi, Price, Valerie, Rawat, Varun, Verma, Pragya, Narayanan, Vinodh, D'Mello, Santosh R.
• Format: Journal Article
• Language: English
• Published: United States Society for Neuroscience 22.02.2012
• Subjects: Animals; Animals, Newborn; Apoptosis - drug effects; Apoptosis - genetics; Apoptosis - physiology; Cells, Cultured; Cerebellum - cytology; Disease Models, Animal; Female; Forkhead Transcription Factors; Gene Expression Regulation - drug effects; Gene Expression Regulation - genetics; Huntingtin Protein; Huntington Disease - metabolism; Huntington Disease - pathology; Immunoprecipitation; Insulin-Like Growth Factor I - metabolism; Male; Methyl-CpG-Binding Protein 2 - genetics; Methyl-CpG-Binding Protein 2 - metabolism; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitosis; Mutation - genetics; Nerve Tissue Proteins - genetics; Neurons - drug effects; Neurons - metabolism; Neurons - physiology; Neurotoxicity Syndromes - etiology; Neurotoxicity Syndromes - metabolism; Nitro Compounds - toxicity; Nuclear Proteins - genetics; Potassium - pharmacology; Propionates - toxicity; Protein Isoforms - genetics; Protein Isoforms - metabolism; RNA, Messenger - metabolism; RNA, Small Interfering - genetics; RNA, Small Interfering - metabolism; RNA, Small Interfering - pharmacology; Signal Transduction - drug effects; Signal Transduction - physiology; Transfection
• ISSN: 0270-6474; 1529-2401; 1529-2401
• DOI: 10.1523/JNEUROSCI.5841-11.2012

The methyl-CpG binding protein 2 (MeCP2) is a widely expressed protein, the mutations of which cause Rett syndrome. The level of MeCP2 is highest in the brain where it is expressed selectively in mature neurons. Its functions in postmitotic neurons are not known. The MeCP2 gene is alternatively spliced to generate two proteins with different N termini, designated as MeCP2-e1 and MeCP2-e2 . The physiological significance of these two isoforms has not been elucidated, and it is generally assumed they are functionally equivalent. We report that in cultured cerebellar granule neurons induced to die by low potassium treatment and in Aβ-treated cortical neurons, Mecp2-e2 expression is upregulated whereas expression of the Mecp2-e1 isoform is downregulated. Knockdown of Mecp2-e2 protects neurons from death, whereas knockdown of the e1 isoform has no effect. Forced expression of MeCP2-e2, but not MeCP2-e1, promotes apoptosis in otherwise healthy neurons. We find that MeCP2-e2 interacts with the forkhead protein FoxG1, mutations of which also cause Rett syndrome. FoxG1 has been shown to promote neuronal survival and its downregulation leads to neuronal death. We find that elevated FoxG1 expression inhibits MeCP2-e2 neurotoxicity. MeCP2-e2 neurotoxicity is also inhibited by IGF-1, which prevents the neuronal death-associated downregulation of FoxG1 expression, and by Akt, the activation of which is necessary for FoxG1-mediated neuroprotection. Finally, MeCP2-e2 neurotoxicity is enhanced if FoxG1 expression is suppressed or in neurons cultured from FoxG1 -haplodeficient mice. Our results indicate that Mecp2-e2 promotes neuronal death and that this activity is normally inhibited by FoxG1. Reduced FoxG1expression frees MecP2-e2 to promote neuronal death.